WEEKLY WRAPUP
May 20-21, 2017
Greetings!

It's been another wild week in the news, as you've probably noticed, thanks in large part to the President who James Grant aptly named "The Avatar of Tail Risk," but business continues apace... including the business of hinting at ridiculous little penny stocks to get the attention of new subscribers.  So our work here at Stock Gumshoe stays on track, tail risk or no... what was dangled as bait for us this week?  

We started out by sniffing out the "Soldier Super Sight" stock teased by Defense Technology Alert -- as always, the potential is absurdly overpromised... but there is an actual little company hiding under the  hype, just click below to...

With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas for the year ahead. One of the companies highlighted in this report controls the smartphone market and now has its sights set on owning a bigger technology. It has the potential to be the most valuable stock in the history of investing. You need to find out the name of this company before the rest of the market does. This Report Is Completely Free, Download Your Copy Today
Advertisement
Lots of defense-related newsletter teasers have been flowing through Gumshoe HQ over the past six months, mostly because newsletters are hoping to profit from any Trump increase to defense budgets -- this latest one from The Casey Report is all about "penny defense stocks," with the argument that these little companies will surge like their predecessors did 75 years ago, becoming the next titans of the Military Industrial Complex.  So what are they?  My story is here.

We also saw a revamped version of the ad about "40 retailers going bankrupt" from the Zenith Trading Circle folks, hinting at a way to profit from their demise by using "carbon trades." Huh?  have no fear, explanation here.

Doc Gumshoe is back in the land of the walking, and he's got a new look at the world of statins and PCSK9 inhibitors and other bulletins from the cardiac front.  Will pricey and profitable new drugs replace cheap statins?  How low should cholesterol be?  How about blood pressure?   Just click here for Doc Gumshoe's latest.

We also saw a (slightly) updated version of the ad from Dr. Kent Moors about an "infinite energy nano-grid" stock -- we've covered that before, but we took a second look this week and you can see that updated story here.  The stock has not yet posted 38,901% gains, surprisingly enough, so you haven't missed much in the past six months they've been touting it.

And finally, I wrapped up the week with my Friday File for the Irregulars, my favorite people -- that included some changes to my Real Money Portfolio, both buys and sells, and some other updates to the companies I follow most closely.  That story is here if you missed the email on Friday.

More to come on Monday... stay tuned!
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060
Sent by travis@stockgumshoe.com in collaboration with
Constant Contact